Patents by Inventor Aarti Jagannath

Aarti Jagannath has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Adenosine receptor modulators for the treatment of circadian rhythm disorders
    Patent number: 11931374
    Abstract: The present invention relates to the use of adenosine receptor modulators to affect the circadian rhythm, in particular, to the use of such modulators for the treatment of circadian rhythm disorders. In particular, the invention relates to a composition comprising at least one selective adenosine receptor modulator, wherein said composition modulates two or three, but not all of adenosine receptor subtypes A1, A2A, A2B and/or A3 for use in the treatment of circadian rhythm disorders or for modulating a biological clock.
    Type: Grant
    Filed: June 25, 2020
    Date of Patent: March 19, 2024
    Assignee: OXFORD UNIVERSITY INNOVATION LIMITED
    Inventors: Sridhar Vasudevan, Aarti Jagannath, Russell Foster
  • Adenosine Receptor Modulators for the Treatment of Circadian Rhythm Disorders
    Publication number: 20210106605
    Abstract: The present invention relates to the use of adenosine receptor modulators to affect the circadian rhythm, in particular, to the use of such modulators for the treatment of circadian rhythm disorders. In particular, the invention relates to a composition comprising at least one selective adenosine receptor modulator, wherein said composition modulates two or three, but not all of adenosine receptor subtypes A1, A2A, A2B and/or A3 for use in the treatment of circadian rhythm disorders or for modulating a biological clock.
    Type: Application
    Filed: June 25, 2020
    Publication date: April 15, 2021
    Inventors: Sridhar Vasudevan, Aarti Jagannath, Russell Foster
  • Adenosine Receptor Modulators for the Treatment of Circadian Rhythm Disorders
    Publication number: 20190111069
    Abstract: The present invention relates to the use of adenosine receptor modulators to affect the circadian rhythm, in particular, to the use of such modulators for the treatment of circadian rhythm disorders. In particular, the invention relates to a composition comprising at least one selective adenosine receptor modulator, wherein said composition modulates two or three, but not all of adenosine receptor subtypes A1, A2A, A2B and/or A3 for use in the treatment of circadian rhythm disorders or for modulating a biological clock.
    Type: Application
    Filed: April 12, 2017
    Publication date: April 18, 2019
    Inventors: Sridhar Vasudevan, Aarti Jagannath, Russell Foster